Bloomberg Markets and Finance published this video item, entitled “Novo Nordisk Raises Forecasts on New Obesity Drug” – below is their description.
Aug.05 — Lars Fruergaard Jorgensen, Novo Nordisk chief executive officer, discusses first half earnings results. The Danish drug-maker raised its profit and sales forecasts for the year, reflecting high demand for its new obesity medication. He speaks with Bloomberg’s Dani Burger on “Bloomberg Surveillance: Early Edition”.Bloomberg Markets and Finance YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.